Citius pharmaceuticals reports positive results from recent data monitoring committee meeting for mino-lok phase 3 trial

Citius pharmaceuticals reports positive results from recent data monitoring committee meeting for mino-lok phase 3 trial.citius pharmaceuticals inc - dmc makes recommendation to continue trial with no modifications and requests an ad hoc meeting in near future.citius pharmaceuticals inc - dmc members stated that they did not find any safety signals.citius pharmaceuticals inc - dmc further requested to have an ad hoc meeting in near future..
CTXR Ratings Summary
CTXR Quant Ranking